Profiel
Richard A. Silva is Senior Vice President-Technical Operations at LB Pharmaceuticals, Inc. since 2025.
Formerly, Dr. Silva was Senior Vice President-Pharmaceutical Sciences at Carmot Therapeutics, Inc. from 2023 to 2024, VP-Technical Operations & Development at Epizyme, Inc. from 2020 to 2023, Senior Director at Kaleido Biosciences, Inc. from 2019 to 2020, and Senior Director-Chemical Process Development at ImmunoGen, Inc. from 2015 to 2019.
Education includes a doctorate from Dartmouth College and an undergraduate degree from the University of Massachusetts.
Actieve functies van Richard Silva
| Bedrijven | Functie | Begin |
|---|---|---|
| LB PHARMACEUTICALS INC | Hoofd Techniek/Wetenschap/O&O | 01-02-2025 |
Eerdere bekende functies van Richard Silva
| Bedrijven | Functie | Einde |
|---|---|---|
Carmot Therapeutics, Inc.
Carmot Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops drugs for inflammatory, metabolic and neurological diseases | Corporate Officer/Principal | 01-07-2024 |
| EPIZYME, INC. | Corporate Officer/Principal | 01-04-2023 |
| KALEIDO BIOSCIENCES, INC. | Directeur/Bestuurslid | 01-02-2020 |
| IMMUNOGEN, INC. | Corporate Officer/Principal | 01-03-2019 |
Opleiding van Richard Silva
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
ImmunoGen, Inc.
ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Carmot Therapeutics, Inc.
Carmot Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops drugs for inflammatory, metabolic and neurological diseases | Health Technology |
Kaleido Biosciences, Inc.
Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
LB Pharmaceuticals, Inc.
LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
















